Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Securities and Exchange Commission. DATED JUNE 20, 2013 DISTRIBUTION AND LICENSING AGREEMENTDistribution and Licensing Agreement • June 25th, 2014 • CareDx, Inc. • Services-medical laboratories • London
NOW THEREFORE, in consideration of the mutual covenants contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows:
EXHIBIT 10.1 ------------ Amendment No. 2 to Distribution and Licensing Agreement between the Registrant and Kamar, Inc. dated September 28, 2000(1) (1)Confidential Treatment as to certain portions has been requested effective until December 31, 2004....Distribution and Licensing Agreement • November 13th, 2000 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances
ContractDistribution and Licensing Agreement • December 2nd, 2017 • Washington
Agreement Remarks This Distribution and Licensing Agreement (the “Agreement”) is made and entered this st day of , 2016 (the “Effective Date”) by and between ., a corporation to be organized and exist under the laws of _ (“Licensor”) and ., a corporation (“Company” and collectively with Licensor, the “Parties” and each, a “Party”). [1] [1] The framework of the license and distribution is critical as well as the State under which the individual companies were formed. This must be kept in mind throughout the various provisions of the agreement.Specifying the identities of the involved parties ensures that all parties know Licensor and Company (Licensee). This allows for the parties to verify who owns the claimed invention (licensor) and who intends to commercialize the claimed invention (licensee). An alternative to the term “Company” could be “Licensee.” W I T N E S S E T H: WHEREAS, Licensor is engaged, inter alia, in the development, licensing, and distribution of certain Products, as
BINTAI KINDEN CORPORATION BERHADDistribution and Licensing Agreement • October 6th, 2020
Distribution and Licensing Agreement between Bintai Healthcare Sdn Bhd and Generex Biotechnology Corporation and NuGenerex Immuno-Oncology, Inc.
AMENDMENT NO. 6 TRANSITION AND PHASE OUT AGREEMENT RELATED TO DISTRIBUTION AND LICENSING AGREEMENTDistribution and Licensing Agreement • October 4th, 2012 • Black Diamond, Inc. • Sporting & athletic goods, nec • New York
THIS Agreement, dated as of the 28th day of September 2012 (the “Effective Date”), shall supersede the Distribution and Licensing Agreement and all related Amendments by and between Gregory Mountain Products, LLC, a Delaware limited liability company doing business as Gregory Mountain Products (hereinafter referred to as "Gregory"), and Kabushiki Kaisha A&F, a Japanese corporation (hereinafter referred to as the "Licensee"). Gregory and Licensee hereinafter sometimes are referred to individually as a "Party" and collectively as the "Parties."
DISTRIBUTION AND LICENSING AGREEMENTDistribution and Licensing Agreement • February 28th, 2012 • Theratechnologies Inc. • Pharmaceutical preparations • England and Wales
THIS DISTRIBUTION AND LICENSING AGREEMENT (hereinafter the “Agreement”) is made and entered into as of this 3rd day of February, 2011 (hereinafter the “Effective Date”),
DATED THIS DAY OF 05 OCT 2020 BETWEEN GENEREX BIOTECHNOLOGY CORPORATION ("GENEREX") AND NUGENEREX IMMUNO-ONCOLOGY, INC. (''NUGENEREX") AND BINTAI HEALTHCARE SDN BHD ("BHSB") DISTRIBUTION AND LICENSING AGREEMENTDistribution and Licensing Agreement • October 14th, 2020 • Nugenerex Immuno-Oncology, Inc. • Pharmaceutical preparations
NuGenerex Immuno-Oncology, Inc. a majority owned subsidiary of Generex Biotechnology Corporation, each a Delaware corporation with an office address of 10102 USA Today Way, Miramar, FL 33025 ("NuGenerex")
DISTRIBUTION and licensing AGREEMENTDistribution and Licensing Agreement • February 11th, 2021 • Sparbar, Inc. • New York
This Agreement is effective this __ day of ____, 2020 (“Effective Date”), by and between Sparbar LTD, a corporation organized and existing under the laws of the United Kingdom (“Manufacturer”), and Sparbar Inc., a Delaware Corporation (“Distributor”).
Distribution and licensing agreement for Generx [Ad5FGF-4]Distribution and Licensing Agreement • July 15th, 2024
TERM SHEET FOR Prana “Bio Nutrient Medicinals” Distribution and Licensing AgreementDistribution and Licensing Agreement • March 7th, 2017 • United Cannabis Corp • Pharmaceutical preparations
This Term Sheet is to definitively agree to a Distribution and Licensing Agreement by and between UCANN California Corporation, (“UCANN” or “Licensor”) a California corporation whose address is 1600 Broadway, Suite 1600, Denver, Colorado 80202 and Patients Mutual Assistance Collective Corporation, a California corporation dba Harborside Health Center (“Harborside” or “Licensee”) located at 1840 Embarcadero, Oakland, California 94606. UCANN and Licensee may be referred to herein collectively as the “Parties” on the following terms:
DISTRIBUTION AND LICENSING AGREEMENTDistribution and Licensing Agreement • February 28th, 2012 • Theratechnologies Inc. • Pharmaceutical preparations • England and Wales
THIS DISTRIBUTION AND LICENSING AGREEMENT (hereinafter the “Agreement”) is made and entered into as of December 6th, 2010 (hereinafter the “Effective Date”)
EXHIBIT 10.32 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. DISTRIBUTION AND LICENSING AGREEMENT (CPU-Standard Point and Click/ With or Without Insert) THIS AGREEMENT (the...Distribution and Licensing Agreement • September 25th, 1998 • Prodigy Communications Inc
Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Securities and Exchange Commission. DATED JUNE 20, 2013 DISTRIBUTION AND LICENSING AGREEMENTDistribution and Licensing Agreement • March 31st, 2014 • CareDx, Inc. • Services-medical laboratories • London
NOW THEREFORE, in consideration of the mutual covenants contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows:
